56 results
Search Results
2. IPSCs put to the test.
- Author
-
Kim, Hyesoo and Studer, Lorenz
- Subjects
- *
STEM cells , *EMBRYONIC stem cells , *CELL lines , *CYTOLOGICAL research - Abstract
The authors comment on G. L. Boulting's paper that compares differentiation behavior across a set of human induced pluripotent stem cells (iPSC) and embryonic stem cell (ESC) lines. They say that Boulting's paper suggests that the mean differentiation performance of human iPSC and ESC lines cannot be distinguished and that simple changes in culture conditions can rescue poorly performing iPSC lines. They also discussed the questions raised by the advent of iPSC technology about the reversibility and molecular control of differentiated cell fates.
- Published
- 2011
- Full Text
- View/download PDF
3. Five more years of Nature Biotechnology research.
- Author
-
Baker, Monya and DeFrancesco, Laura
- Subjects
BIOTECHNOLOGY ,EMBRYONIC stem cells ,GENETIC research - Abstract
The article provides information on the most important advances in biotechnology that were published in the 2005 to 2010 issues of "Nature Biotechnology." It says that the creation of induced pluripotent stem (iPS) cells is one of the most important discoveries, which Shinya Yamanaka of Kyoto University showed by inserting transcription factors into cultured mouse fibroblasts that could make them act like embryonic stem cells. The author adds that George Church of Harvard University in Massachusetts compared epigenomes and genomes across samples in 2009.
- Published
- 2011
- Full Text
- View/download PDF
4. Karyotype of human ES cells during extended culture.
- Author
-
Andrews, Peter W.
- Subjects
LETTERS to the editor ,EMBRYONIC stem cells - Abstract
Presents a response by Peter W. Andrews to a letter to the editor about his paper on karyotype abnormalities in cultured human embryonic stem (hES) cell lines.
- Published
- 2004
- Full Text
- View/download PDF
5. Trends in the biotech literature.
- Author
-
Lawrence, Stacy
- Subjects
- *
BIOTECHNOLOGY research , *CASE studies , *GENE therapy , *EMBRYONIC stem cells , *T cells - Abstract
The article presents data related to biotechnology research papers in the U.S. The US remains the most productive country in terms of biotech-related papers. But numbers of papers from the European Union surpassed the US last year (with Germany and the UK ahead of most EU countries); elsewhere, Korea, China and Japan also publish frequently. Some of the top cited papers, published in different journals, by field are: RNAi--Systematic functional analysis of the Caenorhabditis elegans genome using RNAi; Gene therapy--LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X2 and Nuclear transfer--Derivation of oocytes from mouse embryonic stem cells.
- Published
- 2005
- Full Text
- View/download PDF
6. Stem cells in a new light.
- Author
-
Klassen, Henry and Reubinoff, Benjamin
- Subjects
- *
PHOTORECEPTORS , *EMBRYONIC stem cells , *RETINAL diseases , *STEM cells , *PHOTOBIOLOGY , *MICE , *MONKEYS , *HUMAN beings , *BIOTECHNOLOGY - Abstract
The article discusses a study which shows that putative photoreceptors derived from embryonic stem (ES) cells holds promise in treating retinal diseases. In this paper published within this issue, Masayo Takahashi and colleagues developed an efficient and stepwide protocol for the derivation of photoreceptor-like cells from ES cells of mouse, monkey and human using defined culture conditions. Although, it is indicated in the study that the photoreceptors derived in the ES cell show appropriate morphology and express genes involved in the phototransduction, the authors have minor doubt on the photoreceptors' efficiency, arguing that its functionality is yet to be demonstrated, specifically after transplantation.
- Published
- 2008
- Full Text
- View/download PDF
7. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.
- Author
-
Wu, Xuebing, Scott, David A, Kriz, Andrea J, Chiu, Anthony C, Hsu, Patrick D, Dadon, Daniel B, Cheng, Albert W, Trevino, Alexandro E, Konermann, Silvana, Chen, Sidi, Jaenisch, Rudolf, Zhang, Feng, and Sharp, Phillip A
- Subjects
CRISPRS ,ENDONUCLEASES ,GENETIC transcription ,RNA editing ,EUKARYOTIC cell genetics ,EMBRYONIC stem cells ,STREPTOCOCCUS pyogenes ,LABORATORY mice - Abstract
Bacterial type II CRISPR-Cas9 systems have been widely adapted for RNA-guided genome editing and transcription regulation in eukaryotic cells, yet their in vivo target specificity is poorly understood. Here we mapped genome-wide binding sites of a catalytically inactive Cas9 (dCas9) from Streptococcus pyogenes loaded with single guide RNAs (sgRNAs) in mouse embryonic stem cells (mESCs). Each of the four sgRNAs we tested targets dCas9 to between tens and thousands of genomic sites, frequently characterized by a 5-nucleotide seed region in the sgRNA and an NGG protospacer adjacent motif (PAM). Chromatin inaccessibility decreases dCas9 binding to other sites with matching seed sequences; thus 70% of off-target sites are associated with genes. Targeted sequencing of 295 dCas9 binding sites in mESCs transfected with catalytically active Cas9 identified only one site mutated above background levels. We propose a two-state model for Cas9 binding and cleavage, in which a seed match triggers binding but extensive pairing with target DNA is required for cleavage. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.
- Author
-
Lee, E-Chiang, Liang, Qi, Ali, Hanif, Bayliss, Luke, Beasley, Alastair, Bloomfield-Gerdes, Tara, Bonoli, Laura, Brown, Richard, Campbell, Jamie, Carpenter, Adam, Chalk, Sara, Davis, Alison, England, Nick, Fane-Dremucheva, Alla, Franz, Bettina, Germaschewski, Volker, Holmes, Helen, Holmes, Steve, Kirby, Ian, and Kosmac, Miha
- Subjects
IMMUNOGLOBULINS ,TRANSGENIC mice ,EMBRYONIC stem cells ,ANTIBODY formation ,RECOMBINASES ,MONOCLONAL antibodies - Abstract
If immunized with an antigen of interest, transgenic mice with large portions of unrearranged human immunoglobulin loci can produce fully human antigen-specific antibodies; several such antibodies are in clinical use. However, technical limitations inherent to conventional transgenic technology and sequence divergence between the human and mouse immunoglobulin constant regions limit the utility of these mice. Here, using repetitive cycles of genome engineering in embryonic stem cells, we have inserted the entire human immunoglobulin variable-gene repertoire (2.7 Mb) into the mouse genome, leaving the mouse constant regions intact. These transgenic mice are viable and fertile, with an immune system resembling that of wild-type mice. Antigen immunization results in production of high-affinity antibodies with long human-like complementarity-determining region 3 (CDR3H), broad epitope coverage and strong signatures of somatic hypermutation. These mice provide a robust system for the discovery of therapeutic human monoclonal antibodies; as a surrogate readout of the human antibody response, they may also aid vaccine design efforts. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.
- Author
-
Koike-Yusa, Hiroko, Li, Yilong, Tan, E-Pien, Velasco-Herrera, Martin Del Castillo, and Yusa, Kosuke
- Subjects
GENETIC testing ,RNA interference ,PALINDROMIC DNA ,LENTIVIRUSES ,GENETIC mutation ,EMBRYONIC stem cells ,EXONS (Genetics) - Abstract
Identification of genes influencing a phenotype of interest is frequently achieved through genetic screening by RNA interference (RNAi) or knockouts. However, RNAi may only achieve partial depletion of gene activity, and knockout-based screens are difficult in diploid mammalian cells. Here we took advantage of the efficiency and high throughput of genome editing based on type II, clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems to introduce genome-wide targeted mutations in mouse embryonic stem cells (ESCs). We designed 87,897 guide RNAs (gRNAs) targeting 19,150 mouse protein-coding genes and used a lentiviral vector to express these gRNAs in ESCs that constitutively express Cas9. Screening the resulting ESC mutant libraries for resistance to either Clostridium septicum alpha-toxin or 6-thioguanine identified 27 known and 4 previously unknown genes implicated in these phenotypes. Our results demonstrate the potential for efficient loss-of-function screening using the CRISPR-Cas9 system. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
10. Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape.
- Author
-
Sherwood, Richard I, Hashimoto, Tatsunori, O'Donnell, Charles W, Lewis, Sophia, Barkal, Amira A, van Hoff, John Peter, Karun, Vivek, Jaakkola, Tommi, and Gifford, David K
- Subjects
TRANSCRIPTION factors ,DEOXYRIBONUCLEASES ,PROTEIN-protein interactions ,BINDING sites ,IMMUNOPRECIPITATION ,EMBRYONIC stem cells ,CHROMATIN - Abstract
We describe protein interaction quantitation (PIQ), a computational method for modeling the magnitude and shape of genome-wide DNase I hypersensitivity profiles to identify transcription factor (TF) binding sites. Through the use of machine-learning techniques, PIQ identified binding sites for >700 TFs from one DNase I hypersensitivity analysis followed by sequencing (DNase-seq) experiment with accuracy comparable to that of chromatin immunoprecipitation followed by sequencing (ChIP-seq). We applied PIQ to analyze DNase-seq data from mouse embryonic stem cells differentiating into prepancreatic and intestinal endoderm. We identified 120 and experimentally validated eight 'pioneer' TF families that dynamically open chromatin. Four pioneer TF families only opened chromatin in one direction from their motifs. Furthermore, we identified 'settler' TFs whose genomic binding is principally governed by proximity to open chromatin. Our results support a model of hierarchical TF binding in which directional and nondirectional pioneer activity shapes the chromatin landscape for population by settler TFs. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina.
- Author
-
Gonzalez-Cordero, Anai, West, Emma L, Pearson, Rachael A, Duran, Yanai, Carvalho, Livia S, Chu, Colin J, Naeem, Arifa, Blackford, Samuel J I, Georgiadis, Anastasios, Lakowski, Jorn, Hubank, Mike, Smith, Alexander J, Bainbridge, James W B, Sowden, Jane C, and Ali, Robin R
- Subjects
PHOTORECEPTORS ,THREE-dimensional imaging ,EMBRYONIC stem cells ,CELL culture ,RETINAL degeneration ,DISEASES in adults ,BLINDNESS ,CELLULAR therapy - Abstract
Irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy. We previously demonstrated retinal repair and restoration of vision through transplantation of photoreceptor precursors obtained from postnatal retinas into visually impaired adult mice. Considerable progress has been made in differentiating embryonic stem cells (ESCs) in vitro toward photoreceptor lineages. However, the capability of ESC-derived photoreceptors to integrate after transplantation has not been demonstrated unequivocally. Here, to isolate photoreceptor precursors fit for transplantation, we adapted a recently reported three-dimensional (3D) differentiation protocol that generates neuroretina from mouse ESCs. We show that rod precursors derived by this protocol and selected via a GFP reporter under the control of a Rhodopsin promoter integrate within degenerate retinas of adult mice and mature into outer segment-bearing photoreceptors. Notably, ESC-derived precursors at a developmental stage similar to postnatal days 4-8 integrate more efficiently compared with cells at other stages. This study shows conclusively that ESCs can provide a source of photoreceptors for retinal cell transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
12. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
- Author
-
Tang, Chad, Lee, Andrew S, Volkmer, Jens-Peter, Sahoo, Debashis, Nag, Divya, Mosley, Adriane R, Inlay, Matthew A, Ardehali, Reza, Chavez, Shawn L, Pera, Renee Reijo, Behr, Barry, Wu, Joseph C, Weissman, Irving L, and Drukker, Micha
- Subjects
IMMUNOGLOBULINS ,ANTIGENS ,EMBRYONIC stem cells ,TERATOMA ,IMMUNOHISTOCHEMISTRY - Abstract
An important risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation by residual undifferentiated cells. We raised a monoclonal antibody against hESCs, designated anti-stage-specific embryonic antigen (SSEA)-5, which binds a previously unidentified antigen highly and specifically expressed on hPSCs-the H type-1 glycan. Separation based on SSEA-5 expression through fluorescence-activated cell sorting (FACS) greatly reduced teratoma-formation potential of heterogeneously differentiated cultures. To ensure complete removal of teratoma-forming cells, we identified additional pluripotency surface markers (PSMs) exhibiting a large dynamic expression range during differentiation: CD9, CD30, CD50, CD90 and CD200. Immunohistochemistry studies of human fetal tissues and bioinformatics analysis of a microarray database revealed that concurrent expression of these markers is both common and specific to hPSCs. Immunodepletion with antibodies against SSEA-5 and two additional PSMs completely removed teratoma-formation potential from incompletely differentiated hESC cultures. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. A resource of vectors and ES cells for targeted deletion of microRNAs in mice.
- Author
-
Prosser, Haydn M, Koike-Yusa, Hiroko, Cooper, James D, Law, Frances C, and Bradley, Allan
- Subjects
RNA ,EMBRYONIC stem cells ,MICE ,CHIMERISM ,GERM cells - Abstract
The 21-23 nucleotide, single-stranded RNAs classified as microRNAs (miRNA) perform fundamental roles in diverse cellular and developmental processes. In contrast to the situation for protein-coding genes, no public resource of miRNA mouse mutant alleles exists. Here we describe a collection of 428 miRNA targeting vectors covering 476 of the miRNA genes annotated in the miRBase registry. Using these vectors, we generated a library of highly germline-transmissible C57BL/6N mouse embryonic stem (ES) cell clones harboring targeted deletions for 392 miRNA genes. For most of these targeted clones, chimerism and germline transmission can be scored through a coat color marker. The targeted alleles have been designed to be adaptable research tools that can be efficiently altered by recombinase-mediated cassette exchange to create reporter, conditional and other allelic variants. This miRNA knockout (mirKO) resource can be searched electronically and is available from ES cell repositories for distribution to the scientific community. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
14. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells.
- Author
-
Kelly, Olivia G, Chan, Man Yin, Martinson, Laura A, Kadoya, Kuniko, Ostertag, Traci M, Ross, Kelly G, Richardson, Mike, Carpenter, Melissa K, D'Amour, Kevin A, Kroon, Evert, Moorman, Mark, Baetge, Emmanuel E, and Bang, Anne G
- Subjects
CELL membranes ,PANCREATIC beta cells ,EMBRYONIC stem cells ,PLURIPOTENT stem cells ,GENETIC markers - Abstract
Using a flow cytometry-based screen of commercial antibodies, we have identified cell-surface markers for the separation of pancreatic cell types derived from human embryonic stem (hES) cells. We show enrichment of pancreatic endoderm cells using CD142 and of endocrine cells using CD200 and CD318. After transplantation into mice, enriched pancreatic endoderm cells give rise to all the pancreatic lineages, including functional insulin-producing cells, demonstrating that they are pancreatic progenitors. In contrast, implanted, enriched polyhormonal endocrine cells principally give rise to glucagon cells. These antibodies will aid investigations that use pancreatic cells generated from pluripotent stem cells to study diabetes and pancreas biology. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
15. A functionally characterized test set of human induced pluripotent stem cells.
- Author
-
Boulting, Gabriella L., Kiskinis, Evangelos, Croft, Gist F., Amoroso, Mackenzie W., Oakley, Derek H., Wainger, Brian J., Williams, Damian J., Kahler, David J., Yamaki, Mariko, Davidow, Lance, Rodolfa, Christopher T., Dimos, John T., Mikkilineni, Shravani, MacDermott, Amy B., Woolf, Clifford J., Henderson, Christopher E., Wichterle, Hynek, and Eggan, Kevin
- Subjects
STEM cells ,EMBRYONIC stem cells ,ETIOLOGY of diseases ,MEDICAL genetics ,BIOMARKERS ,BIOTECHNOLOGY - Abstract
Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
16. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells.
- Author
-
Green, Michael D., Chen, Antonia, Nostro, Maria-Cristina, D'Souza, Sunita L., Schaniel, Christoph, Lemischka, Ihor R., Gouon-Evans, Valerie, Keller, Gordon, and Snoeck, Hans-Willem
- Subjects
EMBRYONIC stem cells ,STEM cells ,CELL lines ,GENETICS ,CELLULAR therapy ,BIOTECHNOLOGY - Abstract
Directed differentiation of human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells captures in vivo developmental pathways for specifying lineages in vitro, thus avoiding perturbation of the genome with exogenous genetic material. Thus far, derivation of endodermal lineages has focused predominantly on hepatocytes, pancreatic endocrine cells and intestinal cells. The ability to differentiate pluripotent cells into anterior foregut endoderm (AFE) derivatives would expand their utility for cell therapy and basic research to tissues important for immune function, such as the thymus; for metabolism, such as thyroid and parathyroid; and for respiratory function, such as trachea and lung. We find that dual inhibition of transforming growth factor (TGF)-β and bone morphogenic protein (BMP) signaling after specification of definitive endoderm from pluripotent cells results in a highly enriched AFE population that is competent to be patterned along dorsoventral and anteroposterior axes. These findings provide an approach for the generation of AFE derivatives. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
17. >The tabula rasa of cells.
- Subjects
EMBRYONIC stem cells ,STEM cells ,CELL lines ,CELL culture ,CULTURE media (Biology) ,FIBROBLASTS - Abstract
The article presents a study on the in vivo differentiation of human embryonic stem cell lines. The cells were derived with a medium containing mouse fibroblasts. However, the study posed several problems on scaling up the culture and creating reliable techniques to grow a culture from a single embryonic stem cell.
- Published
- 2006
- Full Text
- View/download PDF
18. Directed differentiation of human embryonic stem cells toward chondrocytes.
- Author
-
Oldershaw, Rachel A., Baxter, Melissa A., Lowe, Emma T., Bates, Nicola, Grady, Lisa M., Soncin, Francesca, Brison, Daniel R., Hardingham, Timothy E., and Kimber, Susan J.
- Subjects
EMBRYONIC stem cells ,CARTILAGE cells ,EXTRACELLULAR matrix proteins ,GENE expression ,CELLS ,TRANSCRIPTION factors - Abstract
We report a chemically defined, efficient, scalable and reproducible protocol for differentiation of human embryonic stem cells (hESCs) toward chondrocytes. HESCs are directed through intermediate developmental stages using substrates of known matrix proteins and chemically defined media supplemented with exogenous growth factors. Gene expression analysis suggests that the hESCs progress through primitive streak or mesendoderm to mesoderm, before differentiating into a chondrocytic culture comprising cell aggregates. At this final stage, 74% (HUES1 cells) and up to 95-97% (HUES7 and HUES8 cells) express the chondrogenic transcription factor SOX9. The cell aggregates also express cell surface CD44 and aggrecan and deposit a sulfated glycosaminoglycan and cartilage-specific collagen II matrix, but show very low or no expression of genes and proteins associated with nontarget cell types. Our protocol should facilitate studies of chondrocyte differentiation and of cell replacement therapies for cartilage repair. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
19. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells.
- Author
-
Melkoumian, Zara, Weber, Jennifer L., Weber, David M., Fadeev, Andrei G., Zhou, Yue, Dolley-Sonneville, Paula, Yang, Jiwei, Qiu, Liqun, Priest, Catherine A., Shogbon, Christopher, Martin, Arthur W., Nelson, Jodelle, West, Peter, Beltzer, James P., Pal, Santona, and Brandenberger, Ralph
- Subjects
EMBRYONIC stem cells ,ACRYLATES ,HEART cells ,CELL differentiation ,CELL culture ,CELLULAR therapy - Abstract
Human embryonic stem cells (hESCs) have two properties of interest for the development of cell therapies: self-renewal and the potential to differentiate into all major lineages of somatic cells in the human body. Widespread clinical application of hESC-derived cells will require culture methods that are low-cost, robust, scalable and use chemically defined raw materials. Here we describe synthetic peptide-acrylate surfaces (PAS) that support self-renewal of hESCs in chemically defined, xeno-free medium. H1 and H7 hESCs were successfully maintained on PAS for over ten passages. Cell morphology and phenotypic marker expression were similar for cells cultured on PAS or Matrigel. Cells on PAS retained normal karyotype and pluripotency and were able to differentiate to functional cardiomyocytes on PAS. Finally, PAS were scaled up to large culture-vessel formats. Synthetic, xeno-free, scalable surfaces that support the self-renewal and differentiation of hESCs will be useful for both research purposes and development of cell therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
20. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511.
- Author
-
Rodin, Sergey, Domogatskaya, Anna, Ström, Susanne, Hansson, Emil M., Chien, Kenneth R., Inzunza, José, Hovatta, Outi, and Tryggvason, Karl
- Subjects
STEM cells ,EMBRYONIC stem cells ,KARYOTYPES ,TERATOMA ,CELL lines ,CELL adhesion - Abstract
We describe a system for culturing human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells on a recombinant form of human laminin-511, a component of the natural hES cell niche. The system is devoid of animal products and feeder cells and contains only one undefined component, human albumin. The hES cells self-renewed with normal karyotype for at least 4 months (20 passages), after which the cells could produce teratomas containing cell lineages of all three germ layers. When plated on laminin-511 in small clumps, hES cells spread out in a monolayer, maintaining cellular homogeneity with approximately 97% OCT4-positive cells. Adhesion of hES cells was dependent on α6β1 integrin. The use of homogeneous monolayer hES or iPS cell cultures provides more controllable conditions for the design of differentiation methods. This xeno-free and feeder-free system may be useful for the development of cell lineages for therapeutic purposes. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
21. Ab initio reconstruction of cell type–specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs.
- Author
-
Guttman, Mitchell, Garber, Manuel, Levin, Joshua Z., Donaghey, Julie, Robinson, James, Adiconis, Xian, Lin Fan, Koziol, Magdalena J., Gnirke, Andreas, Nusbaum, Chad, Rinn, John L., Lander, Eric S., and Regev, Aviv
- Subjects
NUCLEOTIDE sequence ,RNA ,GENES ,EMBRYONIC stem cells ,STEM cells ,GENETIC transcription - Abstract
Massively parallel cDNA sequencing (RNA-Seq) provides an unbiased way to study a transcriptome, including both coding and noncoding genes. Until now, most RNA-Seq studies have depended crucially on existing annotations and thus focused on expression levels and variation in known transcripts. Here, we present Scripture, a method to reconstruct the transcriptome of a mammalian cell using only RNA-Seq reads and the genome sequence. We applied it to mouse embryonic stem cells, neuronal precursor cells and lung fibroblasts to accurately reconstruct the full-length gene structures for most known expressed genes. We identified substantial variation in protein coding genes, including thousands of novel 5′ start sites, 3′ ends and internal coding exons. We then determined the gene structures of more than a thousand large intergenic noncoding RNA (lincRNA) and antisense loci. Our results open the way to direct experimental manipulation of thousands of noncoding RNAs and demonstrate the power of ab initio reconstruction to render a comprehensive picture of mammalian transcriptomes. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
22. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.
- Author
-
Närvä, Elisa, Autio, Reija, Rahkonen, Nelly, Kong, Lingjia, Harrison, Neil, Kitsberg, Danny, Borghese, Lodovica, Itskovitz-Eldor, Joseph, Rasool, Omid, Dvorak, Petr, Hovatta, Outi, Otonkoski, Timo, Tuuri, Timo, Cui, Wei, Brüstle, Oliver, Baker, Duncan, Maltby, Edna, Moore, Harry D., Benvenisty, Nissim, and Andrews, Peter W.
- Subjects
EMBRYONIC stem cells ,CELL culture ,CHROMOSOME abnormalities ,HETEROZYGOSITY ,GENETIC research ,CELL nuclei - Abstract
Prolonged culture of human embryonic stem cells (hESCs) can lead to adaptation and the acquisition of chromosomal abnormalities, underscoring the need for rigorous genetic analysis of these cells. Here we report the highest-resolution study of hESCs to date using an Affymetrix SNP 6.0 array containing 906,600 probes for single nucleotide polymorphisms (SNPs) and 946,000 probes for copy number variations (CNVs). Analysis of 17 different hESC lines maintained in different laboratories identified 843 CNVs of 50 kb–3 Mb in size. We identified, on average, 24% of the loss of heterozygosity (LOH) sites and 66% of the CNVs changed in culture between early and late passages of the same lines. Thirty percent of the genes detected within CNV sites had altered expression compared to samples with normal copy number states, of which >44% were functionally linked to cancer. Furthermore, LOH of the q arm of chromosome 16, which has not been observed previously in hESCs, was detected. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension.
- Author
-
Steiner, Debora, Khaner, Hanita, Cohen, Malkiel, Even-Ram, Sharona, Gil, Yaniv, Itsykson, Pavel, Turetsky, Tikva, Idelson, Maria, Aizenman, Einat, Ram, Rita, Berman-Zaken, Yael, and Reubinoff, Benjamin
- Subjects
EMBRYONIC stem cells ,STEM cells ,CELL culture ,CELL differentiation ,GENETIC research ,HEMATOPOIETIC stem cells ,NEURAL stem cells - Abstract
Undifferentiated human embryonic stem cells (hESCs) are currently propagated on a relatively small scale as monolayer colonies. Culture of hESCs as floating aggregates is widely used for induction of differentiation into embryoid bodies. Here we show that hESC lines can be derived from floating inner cell masses in suspension culture conditions that do not involve feeder cells or microcarriers. This culture system supports prolonged propagation of the pluripotent stem cells as floating clusters without their differentiation into embryoid bodies. HESCs cultivated as aggregates in suspension maintain the expression of pluripotency markers and can differentiate into progeny of the three germ layers both in vitro and in vivo. We further show the controlled differentiation of hESC clusters in suspension into neural spheres. These results pave the way for large-scale expansion and controlled differentiation of hESCs in suspension, which would be valuable in basic and applied research. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
24. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family– and KRAS-dependent lung adenocarcinomas.
- Author
-
Zhou, Yinghui, Rideout III, William M., Zi, Tong, Bressel, Angela, Reddypalli, Shailaja, Rancourt, Rebecca, Woo, Jin-Kyeung, Horner, James W., Chin, Lynda, Chiu, M. Isabel, Bosenberg, Marcus, Jacks, Tyler, Clark, Steven C., DePinho, Ronald A., Robinson, Murray O., and Heyer, Joerg
- Subjects
STOCHASTIC processes ,PROBABILITY theory ,CANCER ,TUMORS ,GENETICS ,EMBRYONIC stem cells ,STEM cells - Abstract
To recapitulate the stochastic nature of human cancer development, we have devised a strategy for generating mouse tumor models that involves stepwise genetic manipulation of embryonic stem (ES) cells and chimera generation. Tumors in the chimeric animals develop from engineered cells in the context of normal tissue. Adenocarcinomas arising in an allelic series of lung cancer models containing HER2 (also known as ERBB2), KRAS or EGFR oncogenes exhibit features of advanced malignancies. Treatment of EGFR
L858R and KRASG12V chimeric models with an EGFR inhibitor resulted in near complete tumor regression and no response to the treatment, respectively, accurately reflecting previous clinical observations. Transcriptome and immunohistochemical analyses reveal that PI3K pathway activation is unique to ERBB family tumors whereas KRAS-driven tumors show activation of the JNK/SAP pathway, suggesting points of therapeutic intervention for this difficult-to-treat tumor category. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
25. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells.
- Author
-
Chan, Elayne M., Ratanasirintrawoot, Sutheera, In-Hyun Park, Manos, Philip D., Yuin-Han Loh, Hongguang Huo, Miller, Justine D., Hartung, Odelya, Rho, Junsung, Ince, Tan A., Daley, George Q., and Schlaeger, Thorsten M.
- Subjects
SOMATIC cells ,STEM cells ,GENE expression ,TRANSCRIPTION factors ,EMBRYONIC stem cells ,IMAGING systems in biology - Abstract
Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by enforced expression of transcription factors. Using serial live imaging of human fibroblasts undergoing reprogramming, we identified distinct colony types that morphologically resemble embryonic stem (ES) cells yet differ in molecular phenotype and differentiation potential. By analyzing expression of pluripotency markers, methylation at the OCT4 and NANOG promoters and differentiation into teratomas, we determined that only one colony type represents true iPS cells, whereas the others represent reprogramming intermediates. Proviral silencing and expression of TRA-1-60, DNMT3B and REX1 can be used to distinguish the fully reprogrammed state, whereas alkaline phosphatase, SSEA-4, GDF3, hTERT and NANOG are insufficient as markers. We also show that reprogramming using chemically defined medium favors formation of fully reprogrammed over partially reprogrammed colonies. Our data define molecular markers of the fully reprogrammed state and highlight the need for rigorous characterization and standardization of putative iPS cells. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
26. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.
- Author
-
Hockemeyer, Dirk, Soldner, Frank, Beard, Caroline, Qing Gao, Mitalipova, Maisam, DeKelver, Russell C., Katibah, George E., Amora, Ranier, Boydston, Elizabeth A., Zeitler, Bryan, Xiangdong Meng, Miller, Jeffrey C., Lei Zhang, Rebar, Edward J., Gregory, Philip D., Urnov, Fyodor D., and Jaenisch, Rudolf
- Subjects
EMBRYONIC stem cells ,GENES ,GENE targeting ,NUCLEASES ,GENE expression ,ZINC-finger proteins - Abstract
Realizing the full potential of human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) requires efficient methods for genetic modification. However, techniques to generate cell type–specific lineage reporters, as well as reliable tools to disrupt, repair or overexpress genes by gene targeting, are inefficient at best and thus are not routinely used. Here we report the highly efficient targeting of three genes in human pluripotent cells using zinc-finger nuclease (ZFN)–mediated genome editing. First, using ZFNs specific for the OCT4 (POU5F1) locus, we generated OCT4-eGFP reporter cells to monitor the pluripotent state of hESCs. Second, we inserted a transgene into the AAVS1 locus to generate a robust drug-inducible overexpression system in hESCs. Finally, we targeted the PITX3 gene, demonstrating that ZFNs can be used to generate reporter cells by targeting non-expressed genes in hESCs and hiPSCs. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
27. Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein.
- Author
-
Eguchi, Akiko, Meade, Bryan R., Yung-Chi Chang, Fredrickson, Craig T., Willert, Karl, Puri, Nitin, and Dowdy, Steven F.
- Subjects
RNA ,HIGH throughput screening (Drug development) ,ANIONS ,T cells ,EMBRYONIC stem cells ,ENDOTHELIUM - Abstract
RNA interference (RNAi) induced by short interfering RNA (siRNA) allows for discovery research and large-scale screening; however, owing to their size and anionic charge, siRNAs do not readily enter cells. Current approaches do not deliver siRNAs into a high percentage of primary cells without cytotoxicity. Here we report an efficient siRNA delivery approach that uses a peptide transduction domain–double-stranded RNA-binding domain (PTD-DRBD) fusion protein. DRBDs bind to siRNAs with high avidity, masking the siRNA's negative charge and allowing PTD-mediated cellular uptake. PTD-DRBD–delivered siRNA induced rapid RNAi in a large percentage of various primary and transformed cells, including T cells, human umbilical vein endothelial cells and human embryonic stem cells. We observed no cytotoxicity, minimal off-target transcriptional changes and no induction of innate immune responses. Thus, PTD-DRBD–mediated siRNA delivery allows efficient gene silencing in difficult-to-transfect primary cell types. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
28. Change the record.
- Subjects
EMBRYONIC stem cells ,HUMAN cloning ,FEDERAL funds market (U.S.) ,HUMAN embryos ,GOVERNMENT aid ,RESEARCH ,BIOETHICS ,STEM cell research - Abstract
Presents the highlights of a report on the derivation of embryonic stem cells from a cloned human embryo in the March issue of "Science". Impact of the limitations of federal funding to US researchers; Criticism of the Council on Bioethics and a report "Monitoring Stem Cell Research" published by it.
- Published
- 2004
- Full Text
- View/download PDF
29. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.
- Author
-
Kroon, Evert, Martinson, Laura A., Kadoya, Kuniko, Bang, Anne G., Kelly, Olivia G., Eliazer, Susan, Young, Holly, Richardson, Mike, Smart, Nora G., Cunningham, Justine, Agulnick, Alan D., D'Amour, Kevin A., Carpenter, Melissa K., and Baetge, Emmanuel E.
- Subjects
CELLULAR therapy ,TREATMENT of diabetes ,EMBRYONIC stem cells ,PANCREATIC beta cells ,CELL transplantation ,LABORATORY mice ,BLOOD sugar ,INSULIN ,C-peptide - Abstract
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human β-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with ∼3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional β-cells, including expression of critical β-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell–derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
30. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells.
- Author
-
Osakada, Fumitaka, Ikeda, Hanako, Mandai, Michiko, Wataya, Takafumi, Watanabe, Kiichi, Yoshimura, Nagahisa, Akaike, Akiori, Sasai, Yoshiki, and Takahashi, Masayo
- Subjects
PHOTORECEPTORS ,EMBRYONIC stem cells ,TISSUES ,FIBROBLAST growth factors ,EPITHELIAL cells ,BLOOD plasma - Abstract
We previously reported the differentiation of mouse embryonic stem (ES) cells into retinal progenitors. However, these progenitors rarely differentiate into photoreceptors unless they are cultured with embryonic retinal tissues. Here we show the in vitro generation of putative rod and cone photoreceptors from mouse, monkey and human ES cells by stepwise treatments under defined culture conditions, in the absence of retinal tissues. With mouse ES cells, Crx
+ photoreceptor precursors were induced from Rx+ retinal progenitors by treatment with a Notch signal inhibitor. Further application of fibroblast growth factors, Shh, taurine and retinoic acid yielded a greater number of rhodopsin+ rod photoreceptors, in addition to default cone production. With monkey and human ES cells, feeder- and serum-free suspension culture combined with Wnt and Nodal inhibitors induced differentiation of Rx+ or Mitf+ retinal progenitors, which produced retinal pigment epithelial cells. Subsequent treatment with retinoic acid and taurine induced photoreceptor differentiation. These findings may facilitate the development of human ES cell–based transplantation therapies for retinal diseases. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
31. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state.
- Author
-
Brown, Brian D., Gentner, Bernhard, Cantore, Alessio, Colleoni, Silvia, Amendola, Mario, Zingale, Anna, Baccarini, Alessia, Lazzari, Giovanna, Galli, Cesare, and Naldini, Luigi
- Subjects
TRANSGENE expression ,MESSENGER RNA ,DENDRITIC cells ,EMBRYONIC stem cells ,CELL differentiation ,ANTIGEN presenting cells ,LANGERHANS cells ,LYMPHOID tissue ,RNA - Abstract
We have shown previously that transgene expression can be suppressed in hematopoietic cells using vectors that are responsive to microRNA (miRNA) regulation. Here we investigate the potential of this approach for more sophisticated control of transgene expression. Analysis of the relationship between miRNA expression levels and target mRNA suppression suggested that suppression depends on a threshold miRNA concentration. Using this information, we generated vectors that rapidly adjust transgene expression in response to changes in miRNA expression. These vectors sharply segregated transgene expression between closely related states of therapeutically relevant cells, including dendritic cells, hematopoietic and embryonic stem cells, and their progeny, allowing positive/negative selection according to the cells' differentiation state. Moreover, two miRNA target sites were combined to restrict transgene expression to a specific cell type in the liver. Notably, the vectors did not detectably perturb endogenous miRNA expression or regulation of natural targets. The properties of miRNA-regulated vectors should allow for safer and more effective therapeutic applications. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
32. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.
- Author
-
Lombardo, Angelo, Genovese, Pietro, Beausejour, Christian M., Colleoni, Silvia, Ya-Li Lee, Kim, Kenneth A., Ando, Dale, Urnov, Fyodor D., Galli, Cesare, Gregory, Philip D., Holmes, Michael C., and Naldini, Luigi
- Subjects
GENETICS ,GENES ,EMBRYONIC stem cells ,STEM cells ,GENOMES ,CELLS ,DNA ,NUCLEIC acids ,TRANSGENES - Abstract
Achieving the full potential of zinc-finger nucleases (ZFNs) for genome engineering in human cells requires their efficient delivery to the relevant cell types. Here we exploited the infectivity of integrase-defective lentiviral vectors (IDLV) to express ZFNs and provide the template DNA for gene correction in different cell types. IDLV-mediated delivery supported high rates (13–39%) of editing at the IL-2 receptor common γ-chain gene (IL2RG) across different cell types. IDLVs also mediated site-specific gene addition by a process that required ZFN cleavage and homologous template DNA, thus establishing a platform that can target the insertion of transgenes into a predetermined genomic site. Using IDLV delivery and ZFNs targeting distinct loci, we observed high levels of gene addition (up to 50%) in a panel of human cell lines, as well as human embryonic stem cells (5%), allowing rapid, selection-free isolation of clonogenic cells with the desired genetic modification. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
33. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.
- Author
-
Laflamme, Michael A., Chen, Kent Y., Naumova, Anna V., Muskheli, Veronica, Fugate, James A., Dupras, Sarah K., Reinecke, Hans, Chunhui Xu, Hassanipour, Mohammad, Police, Shailaja, O'Sullivan, Chris, Collins, Lila, Yinhong Chen, Minami, Elina, Gill, Edward A., Ueno, Shuichi, Chun Yuan, Gold, Joseph, and Murry, Charles E.
- Subjects
HEART cells ,MYOCARDIUM ,MYOCARDIAL infarction ,CORONARY disease ,HEART diseases ,EMBRYONIC stem cells ,CELL differentiation ,CELL transplantation ,BIOTECHNOLOGY - Abstract
Cardiomyocytes derived from human embryonic stem (hES) cells potentially offer large numbers of cells to facilitate repair of the infarcted heart. However, this approach has been limited by inefficient differentiation of hES cells into cardiomyocytes, insufficient purity of cardiomyocyte preparations and poor survival of hES cell–derived myocytes after transplantation. Seeking to overcome these challenges, we generated highly purified human cardiomyocytes using a readily scalable system for directed differentiation that relies on activin A and BMP4. We then identified a cocktail of pro-survival factors that limits cardiomyocyte death after transplantation. These techniques enabled consistent formation of myocardial grafts in the infarcted rat heart. The engrafted human myocardium attenuated ventricular dilation and preserved regional and global contractile function after myocardial infarction compared with controls receiving noncardiac hES cell derivatives or vehicle. The ability of hES cell–derived cardiomyocytes to partially remuscularize myocardial infarcts and attenuate heart failure encourages their study under conditions that closely match human disease. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
34. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell–derived hepatocytes.
- Author
-
Soto-Gutiérrez, Alejandro, Kobayashi, Naoya, Rivas-Carrillo, Jorge David, Navarro-Álvarez, Nalu, Debaio Zhao, Okitsu, Teru, Noguchi, Hirofumi, Basma, Hesham, Tabata, Yashuhiko, Yong Chen, Tanaka, Kimiaki, Narushima, Michiki, Miki, Atsushi, Ueda, Tadayoshi, Hee-Sook Jun, Ji-Won Yoon, Lebkowski, Jane, Tanaka, Noriaki, and Fox, Ira J.
- Subjects
LIVER failure ,IMMUNOSUPPRESSION ,EMBRYONIC stem cells ,CELLULAR therapy ,LIVER cells - Abstract
Severe acute liver failure, even when transient, must be treated by transplantation and lifelong immune suppression. Treatment could be improved by bioartificial liver (BAL) support, but this approach is hindered by a shortage of human hepatocytes. To generate an alternative source of cells for BAL support, we differentiated mouse embryonic stem (ES) cells into hepatocytes by coculture with a combination of human liver nonparenchymal cell lines and fibroblast growth factor-2, human activin-A and hepatocyte growth factor. Functional hepatocytes were isolated using albumin promoter–based cell sorting. ES cell–derived hepatocytes expressed liver-specific genes, secreted albumin and metabolized ammonia, lidocaine and diazepam. Treatment of 90% hepatectomized mice with a subcutaneously implanted BAL seeded with ES cell–derived hepatocytes or primary hepatocytes improved liver function and prolonged survival, whereas treatment with a BAL seeded with control cells did not. After functioning in the BAL, ES cell–derived hepatocytes developed characteristics nearly identical to those of primary hepatocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
35. Can science resolve the ethical impasse in stem cell research?
- Author
-
Snyder, Evan Y., Hinman, Lawrence M., and Kalichman, Michael W.
- Subjects
EMBRYONIC stem cells ,CYTOLOGICAL research ,BLASTODERM ,HUMAN cloning ,HUMAN beings - Abstract
The article comments on the ethical deadlock in stem cell research. Approaches in the understanding of the control of early human embryonic development could extend solutions to the moral dilemmas affiliated with human embryonic stem cell research, the author stressed. He added that the issue regarding the derivation of stem cells from human blastocysts depends how an individual defines a human being.
- Published
- 2006
- Full Text
- View/download PDF
36. New sources of pancreatic β-cells.
- Author
-
Bonner-Weir, Susan and Weir, Gordon C.
- Subjects
PANCREATIC beta cells ,GROWTH factors ,EMBRYONIC stem cells ,PANCREAS ,PEPTIDE hormones ,ENDOCRINE diseases - Abstract
Two major initiatives are under way to correct the β-cell deficit of diabetes: one would generate β-cells ex vivo that are suitable for transplantation, and the second would stimulate regeneration of β-cells in the pancreas. Studies of ex vivo expansion suggest that β-cells have a potential for dedifferentiation, expansion, and redifferentiation. Work with mouse and human embryonic stem (ES) cells has not yet produced cells with the phenotype of true β-cells, but there has been recent progress in directing ES cells to endoderm. Putative islet stem/progenitor cells have been identified in mouse pancreas, and formation of new β-cells from duct, acinar and liver cells is an active area of investigation. Peptides, including glucagon-like peptide-1/exendin-4 and the combination of epidermal growth factor and gastrin, can stimulate regeneration of β-cells in vivo. Recent progress in the search for new sources of β-cells has opened promising new opportunities and spawned clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
37. Cells repair spinal cord.
- Author
-
Grisham, Julie
- Subjects
SPINAL cord injuries ,THERAPEUTICS ,EMBRYONIC stem cells - Abstract
Studies the use of embryonic stem cells for the treatment of spinal cord damage. Experimentation on oligodendrocytes derived from mouse; Use of immunohistochemical markers to label cells.
- Published
- 2000
- Full Text
- View/download PDF
38. BMP4 initiates human embryonic stem cell differentiation to trophoblast.
- Author
-
Xu, Ren-He, Chen, Xin, Li, Dong S., Li, Rui, Addicks, Gregory C., Glennon, Clay, Zwaka, Thomas P., and Thomson, James A.
- Subjects
EMBRYONIC stem cells ,CELL differentiation ,TROPHOBLAST - Abstract
The excitement and controversy surrounding the potential role of human embryonic stem (ES) cells in transplantation therapy have often overshadowed their potentially more important use as a basic research tool for understanding the development and function of human tissues. Human ES cells can proliferate without a known limit and can form advanced derivatives of all three embryonic germ layers. What is less widely appreciated is that human ES cells can also form the extra-embryonic tissues that differentiate from the embryo before gastrulation. The use of human ES cells to derive early human trophoblast is particularly valuable, because it is difficult to obtain from other sources and is significantly different from mouse trophoblast. Here we show that bone morphogenetic protein 4 (BMP4), a member of the transforming growth factor-β (TGF-β) superfamily, induces the differentiation of human ES cells to trophoblast. DNA microarray, RT-PCR, and immunoassay analyses demonstrate that the differentiated cells express a range of trophoblast markers and secrete placental hormones. When plated at low density, the BMP4treated cells form syncytia that express chorionic gonadotrophin (CG). These results underscore fundamental differences between human and mouse ES cells, which differentiate poorly, if at all, to trophoblast. Human ES cells thus provide a tool for studying the differentiation and function of early human trophoblast and could provide a new understanding of some of the earliest differentiation events of human postimplantation development. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
39. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells.
- Author
-
Richards, Mark, Fong, Chui-Yee, Chan, Woon-Khiong, Wong, Peng-Cheang, and Bongso, Ariff
- Subjects
EMBRYONIC stem cells ,FIBROBLASTS ,ALKALINE phosphatase - Abstract
Previous reports have demonstrated the growth of undifferentiated human embryonic stem (HES) cells on mouse embryonic fibroblast (MEF) feeders and on laminin- or Matrigel-coated plastic surfaces supplemented with MEF-conditioned medium. These xenosupport systems run the risk of cross-transfer of animal pathogens from the animal feeder, matrix, or conditioned medium to the HES cells, thus compromising later clinical application. Here we show that human fetal and adult fibroblast feeders support prolonged undifferentiated HES cell growth of existing cell lines and are superior to cell-free matrices (collagen I, human extracellular matrix, Matrigel, and laminin) supplemented with human or MEF feeder?conditioned medium. Additionally, we report the derivation and establishment of a new HES cell line in completely animal-free conditions. Like HES cells cultured on MEF feeders, the HES cells grown on human feeders had normal karyotypes, tested positive for alkaline phosphatase activity, expressed Oct-4 and cell surface markers including SSEA-3, SSEA-4, Tra 1-60, and GCTM-2, formed teratomas in severely combined immunodeficient (SCID) mice, and retained all key morphological characteristics. Human feeder?supported HES cells should provide a safer alternative to existing HES cell lines in therapeutic applications. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
40. Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation.
- Author
-
Eggan, Kevin, Rode, Anja, Jentsch, Isabell, Samuel, Caroline, Hennek, Thomas, Tintrup, Hartmut, Zevnik, Branko, Erwin, Jennifer, Loring, Janet, Jackson-Grusby, Laurie, Speicher, Michael R., Kuehn, Ralf, and Jaenisch, Rudolf
- Subjects
EMBRYONIC stem cells ,CELL lines ,MICE ,GENETIC mutation - Abstract
We have devised a general strategy for producing female mice from 39,X0 embryonic stem (ES) cells derived from male cell lines carrying a targeted mutation of interest. We show that the Y chromosome is lost in 2% of subclones from 40,XY ES cell lines, making the identification of targeted 39,X0 subclones a routine procedure. After gene targeting, male and female mice carrying the mutation can be generated by tetraploid embryo complementation from the 40,XY ES cell line and its 39,X0 derivatives. A single intercross then produces homozygous mutant offspring. Because this strategy avoids outcrossing and therefore segregation of mutant alleles introduced into the ES cells, the time and expense required for production of experimental mutant animals from a targeted ES cell clone are substantially reduced. Our data also indicate that ES cells have inherently unstable karyotypes, but this instability does not interfere with production of adult ES cell-tetraploid mice. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
41. TALEN-mediated editing of the mouse Y chromosome.
- Author
-
Wang, Haoyi, Hu, Yueh-Chiang, Markoulaki, Styliani, Welstead, G Grant, Cheng, Albert W, Shivalila, Chikdu S, Pyntikova, Tatyana, Dadon, Daniel B, Voytas, Daniel F, Bogdanove, Adam J, Page, David C, and Jaenisch, Rudolf
- Subjects
MICE genetics ,Y chromosome ,ANIMAL models in research ,GENETIC mutation ,NUCLEASES ,EMBRYONIC stem cells - Abstract
The functional study of Y chromosome genes has been hindered by a lack of mouse models with specific Y chromosome mutations. We used transcription activator-like effector nuclease (TALEN)-mediated gene editing in mouse embryonic stem cells (mESCs) to produce mice with targeted gene disruptions and insertions in two Y-linked genes-Sry and Uty. TALEN-mediated gene editing is a useful tool for dissecting the biology of the Y chromosome. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
42. Patenting pluripotence: the next battle for stem cell intellectual property.
- Author
-
Vrtovec, Katja Triller and Scott, Christopher Thomas
- Subjects
PATENTS ,EMBRYONIC stem cells ,INTELLECTUAL property ,GENES ,CELL lines - Abstract
The article focuses on the rejection of three of James Thomson's foundational embryonic stem (ES) cell patents by the U.S. Patent and Trademark Office (USPTO). It examines the impact of induced pluripotent stem cell discoveries by senior authors James Thomson and Shinya Yamanaka on other research works. It notes that the rejection of their attempts to catch all pluripotent cells may suggest the importance of considering gene signatures when claiming new pluripotent cell lines. It also believes that USPTO's decisions invoke new engagement rules in the campaign for dominance in stem cell intellectual property.
- Published
- 2008
- Full Text
- View/download PDF
43. Towards cell therapy for diabetes.
- Author
-
Madsen, Ole D. and Serup, Palle
- Subjects
EMBRYONIC stem cells ,PANCREATIC beta cells ,PEOPLE with diabetes ,INSULIN research ,PANCREATIC acinar cells ,MEDICAL protocols ,TRANSPLANTATION of organs, tissues, etc. ,THERAPEUTICS - Abstract
The article examines the usage of embryonic stem cells as potential sources of pancreatic beta cells for the transplantation therapy involving diabetic patients. A five step medical protocol based on pancreatic development that converts embryonic stem cells into insulin producing cells is discussed. The article includes suggestions on improving the protocol to produce therapeutic beta cells that resemble human pancreatic beta cells.
- Published
- 2006
- Full Text
- View/download PDF
44. The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research.
- Author
-
Andrews, Peter W., Benvenisty, Nissim, McKay, Ron, Pera, Martin F., Rossant, Janet, Semb, Henrik, and Stacey, Glyn N.
- Subjects
EMBRYONIC stem cells ,CONSORTIA ,MEDICAL research ,CELL lines ,JOINT ventures ,STEM cells - Abstract
The article focuses on the International Stem Cell Initiative that is providing benchmarks for human embryonic stem cell research. An international consortium is comparing the properties of 75 human embryonic stem cell lines. It is critical for progress in the field to understand the similarities and the differences between the various isolates, so that research results from different laboratories can be compared in a meaningful fashion. The International Stem Cell Forum founded in January 2003 and chaired by the Medical Research Council of Great Britain, is a group made up of representatives of medical research funding bodies from 15 countries with the goal of promoting international collaboration and funding support for stem cell research.
- Published
- 2005
- Full Text
- View/download PDF
45. First evaluation of the European hESCreg.
- Author
-
Borstlap, Joeri, Stacey, Glyn, Kurtz, Andreas, Elstner, Anja, Damaschun, Alexander, Arán, Begoña, and Veiga, Anna
- Subjects
LETTERS to the editor ,EMBRYONIC stem cells ,COMPUTER network resources - Abstract
This letter to the editor discusses the European human embryonic stem cell registry (hESC), located at www.hescreg.eu.
- Published
- 2008
- Full Text
- View/download PDF
46. ES cells for troubled hearts.
- Author
-
Rubart, Michael and Field, Loren J.
- Subjects
HEART cells ,EMBRYONIC stem cells ,MYOCARDIAL infarction ,CORONARY disease ,ECHOCARDIOGRAPHY ,DIAGNOSTIC ultrasonic imaging ,CARDIAC imaging ,LABORATORY rats ,ANIMAL models in research - Abstract
The article presents a study that investigates the benefits of cardiomyocytes derived from human embryonic stem cells in rat models of myocardial infarction. Using echocardiography and magnetic resonance imaging, modest decreases in cardiac pump function were observed after ischemia/reperfusion injury that were commensurate with infarct size. The authors have shown that transplantation of hES cell-derived cardiomyocytes can attenuate the progressive dysfunction and adverse remodeling that occurs in rats after myocardial infarction.
- Published
- 2007
- Full Text
- View/download PDF
47. An international gap in human ES cell research.
- Author
-
Owen-Smith, Jason and McCormick, Jennifer
- Subjects
LETTERS to the editor ,EMBRYONIC stem cells - Abstract
A letter to the editor that features the controversy besieges basic and translational research involving human embryonic stem cells is presented.
- Published
- 2006
- Full Text
- View/download PDF
48. New life for sperm-mediated transgenesis?
- Author
-
Robl, James M.
- Subjects
EMBRYONIC stem cells ,GENETICS ,MICROINJECTIONS - Abstract
Studies problems as well as developments associated with genetic modification of animal species. Use of embryonic stem cells for making genetic modification in various animal species; Difficulty associated with the technique of pronuclear microinjection; Developments on the genetic modification technologies.
- Published
- 1999
- Full Text
- View/download PDF
49. Pituitary in a dish.
- Author
-
Aschheim, Kathy
- Subjects
EMBRYONIC stem cells ,PITUITARY gland - Abstract
The article reports on a study which investigated how much intervention is required to coax embryonic stem cells to form complex organ structures, such as the pituitary gland, in vitro.
- Published
- 2012
- Full Text
- View/download PDF
50. Germany permits import of ES cells.
- Author
-
Oduncu, Fuat S.
- Subjects
EMBRYONIC stem cells ,IMPORTS - Abstract
Reports that Germany has allowed the importation of embryonic stem cells for research. Law against production of embryonic stem cells from human blastocysts; Ethical issues of production and destruction of human embryos for research purposes.
- Published
- 2002
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.